Prospective assessment of effects on iron-overload parameters of deferasirox therapy in patients with myelodysplastic syndromes

被引:47
作者
Greenberg, Peter L. [1 ]
Koller, Charles A. [2 ]
Cabantchik, Z. Ioav [3 ]
Warsi, Ghulam [4 ]
Glynos, Tara [4 ]
Paley, Carole [4 ]
Schiffer, Charles [5 ]
机构
[1] Stanford Univ, Ctr Canc, Div Hematol, Stanford, CA 94305 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Hebrew Univ Jerusalem, Jerusalem, Israel
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
关键词
Iron chelation; Deferasirox; Exjade (R); MDS; Pharmacokinetics; MRI; LABILE PLASMA IRON; MAGNETIC-RESONANCE; MYOCARDIAL IRON; THALASSEMIA MAJOR; BETA-THALASSEMIA; HEMOCHROMATOSIS; CHELATION; MUTATIONS; DISEASE; ANEMIAS;
D O I
10.1016/j.leukres.2010.06.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We report the first prospective study evaluating the effects of deferasirox on liver iron concentration (LIC), labile plasma iron (LPI) and pharmacokinetics (PK) along with serum ferritin values in patients with IPSS Low-and Intermediate-1 risk myelodysplastic syndromes (MDS) and evidence of iron overload. Twenty-four heavily transfused MDS patients were enrolled in a planned 52 weeks of therapy. PK studies showed dose-proportional total drug exposure. Data demonstrated that deferasirox was well tolerated and effectively reduced LIC, LPI and serum ferritin in the iron-overloaded patients with MDS who completed 24 and 52 weeks of therapy despite ongoing receipt of red blood cell transfusions. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1560 / 1565
页数:6
相关论文
共 35 条
[1]   Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload [J].
Anderson, LJ ;
Holden, S ;
Davis, B ;
Prescott, E ;
Charrier, CC ;
Bunce, NH ;
Firmin, DN ;
Wonke, B ;
Porter, J ;
Walker, JM ;
Pennell, DJ .
EUROPEAN HEART JOURNAL, 2001, 22 (23) :2171-2179
[2]   Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2*cardiovascular magnetic resonance [J].
Anderson, LJ ;
Westwood, MA ;
Holden, S ;
Davis, B ;
Prescott, E ;
Wonke, B ;
Porter, JB ;
Walker, JM ;
Pennell, DJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (03) :348-355
[3]   Hepatic iron concentration and total body iron stores in thalassemia major. [J].
Angelucci, E ;
Brittenham, GM ;
McLaren, CE ;
Ripalti, M ;
Baronciani, D ;
Giardini, C ;
Galimberti, M ;
Polchi, P ;
Lucarelli, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (05) :327-331
[4]   Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major [J].
Borgna-Pignatti, C ;
Cappellini, MD ;
De Stefano, P ;
Del Vecchio, GC ;
Forni, GL ;
Gamberini, MR ;
Ghilardi, R ;
Piga, A ;
Romeo, MA ;
Zhao, HQ ;
Cnaan, A .
BLOOD, 2006, 107 (09) :3733-3737
[5]  
CAZZOLA M, 1988, BLOOD, V71, P305
[6]   Quantitative mapping of transverse relaxivity (1/T2) in hepatic iron overload:: a single spin-echo imaging methodology [J].
Clark, PR ;
St Pierre, TG .
MAGNETIC RESONANCE IMAGING, 2000, 18 (04) :431-438
[7]   Proton transverse relaxation rate (R2) images of iron-loaded liver tissuepping local tissue iron concentrations with MRI [J].
Clark, PR ;
Chua-anusorn, W ;
St Pierre, TG .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :572-575
[8]  
Cortelezzi A, 2000, Hematol J, V1, P153, DOI 10.1038/sj.thj.6200028
[9]   Reduction in labile plasma iron during treatment with deferasirox, a once-daily oral iron chelator, in heavily iron-overloaded patients with β-thalassaemia [J].
Daar, Shahina ;
Pathare, Anil ;
Nick, Hanspeter ;
Kriemler-Krahn, Ulrike ;
Hmissi, Abdel ;
Habr, Dany ;
Taher, Ali .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (06) :454-457
[10]   Myocardial iron overload assessment by T2*magnetic resonance imaging in adult transfusion dependent patients with acquired anemias [J].
Di Tucci, Anna Angela ;
Matta, Gildo ;
Deplano, Simona ;
Gabbas, Attilio ;
Depau, Cristina ;
Derudas, Daniele ;
Caocci, Giovanni ;
Agus, Annalisa ;
Angelucci, Emanuele .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (09) :1385-1388